EE541 Health Equity Improvements Driven By Faricimab for the Treatment of Diabetic Macular Edema in an Aggregate Distributional Cost-Effectiveness Analysis from an English NHS Perspective
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2519
https://www.valueinhealthjournal.com/article/S1098-3015(23)02709-2/fulltext
Title :
EE541 Health Equity Improvements Driven By Faricimab for the Treatment of Diabetic Macular Edema in an Aggregate Distributional Cost-Effectiveness Analysis from an English NHS Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02709-2&doi=10.1016/j.jval.2023.03.2519
First page :
Section Title :
Open access? :
No
Section Order :
10307